L-Erythrose
CAS: 533-49-3
Ref. 3D-ME00260
| 1g | 797.00 € | ||
| 2g | 1,243.00 € | ||
| 100mg | 238.00 € | ||
| 300mg | 471.00 € | ||
| 500mg | 526.00 € |
Product Information
- (2S,3S)-2,3,4-Trihydroxybutanal
- Erythrose, L-
- Butanal, 2,3,4-trihydroxy-, [S-(R*,R*)]-
- Butanal, 2,3,4-trihydroxy-, (2S,3S)-
L-Erythrose is a monosaccharide that contains an hydroxyl group on the second carbon atom. It can be synthesized by a synthetic scheme involving glycolaldehyde and hydroxylamine. L-Erythrose has been shown to inhibit the enzyme phosphoglycerate kinase, which converts 2-phosphoglycerate into phosphoenolpyruvate. L-Erythrose has also been shown to inhibit dehydroascorbic acid reductase, which converts dehydroascorbic acid into ascorbic acid, and galactitol reductase, which converts galactitol into D-tagatose. The mutant strain of Escherichia coli K12 that was engineered to produce L-erythrose showed a decreased susceptibility to phage infection and an increased resistance to oxidative stress. In addition, the polyol pathway in E. coli was induced by L-erythrose treatment.
Chemical properties
Technical inquiry about: 3D-ME00260 L-Erythrose
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
